Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives

E-ISSN： 1873-5576|13|7|775-778

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.7, 2013-01, pp. : 775-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Immunotherapy of Chronic Myeloid Leukemia CML

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 768-774

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 735-748

Bentham Science Publishers

Access to resources Recommend Favorite

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

By Shimoni Avichai Volchek Yulia Koren-Michowitz Maya Varda-Bloom Nira Somech Raz Shem-Tov Noga Yerushalmi Ronit Nagler Arnon

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 863-871

Blackwell Publishing

Access to resources Recommend Favorite

Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay

Current Drug Targets, Vol. 18, Iss. 4, 2017-02 ,pp. : 377-388

Bentham Science Publishers

Access to resources Recommend Favorite

Haematopoietic stem cell transplantation: indications, clinical developments and future directions

By Boyiadzis Michael Pavletic Steven

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 97-108

Informa Healthcare

Access to resources Recommend Favorite